Last Update Time: 13-Mar-2025 16:00:00
ISIN: INE0JWS01017
Sector: Healthcare
Symbol: VALIANTLAB

Valiant Laboratories Limited

₹80.11 ₹-2.54 (-3.07%) ▼
Prev. Close ₹82.65
Open ₹83.07
Close ₹80.78
Range ₹76.10 - ₹84.12
High ₹85.28
Low ₹80.00
Ind. Close ₹0.00
VWAP ₹82.13

The current stock price of Valiant Laboratories Limited is ₹80.11, with a target price range between ₹76.10 and ₹84.12. The stock has experienced a price change of ₹-2.54 (-3.07%), reflecting recent market volatility.

Today's opening price was ₹83.07, while the previous close stood at ₹82.65.

The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.

For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.

Valiant Laboratories Limited Price Chart

Valiant Laboratories Limited Pre Open Market Overview: 13-Mar-2025

Key Metrics:

  • IEP (Indicative Equilibrium Price): 83.07
  • Previous Close Price: 82.65
  • Change: 0.42%
  • Total Traded Volume: 70
  • Total Buy Quantity: 12,021
  • Total Sell Quantity: 3,650
Price Buy Qty Sell Qty
80.75 2,000.00 0.00
81.00 513.00 0.00
81.20 2.00 0.00
81.40 76.00 0.00
82.00 3.00 0.00
83.07 0.00 226.00
84.25 0.00 53.00
85.00 0.00 49.00
85.45 0.00 20.00
88.00 0.00 200.00

ATO Data:

  • Buy Quantity (ATO): 0
  • Sell Quantity (ATO): 0

Order Book

Bid Qty Ask Qty
0.00 0 0.00 0
0.00 0 0.00 0
0.00 0 0.00 0
0.00 0 0.00 0
0.00 0 0.00 0
Total Buy Quantity: 12021 Total Sell Quantity: 3650

Shareholding Patterns of Valiant Laboratories Limited

Key Trade Statistics of Valiant Laboratories Limited

Trade Information Details
Traded Volume (Lakhs) 0.63
Traded Value (₹ Cr.) 0.52
Total Market Cap (₹ Cr.) 348.08
Free Float Market Cap (₹ Cr.) 87.23
Impact cost 0.38
Quantity Traded 63,033.00
Deliverable Quantity 43,293.00
% of Quantity to Traded 68.68
Security VaR 16.42
Index VaR N/A
VaR Margin 16.42
Extreme Loss Rate 3.5
Adhoc Margin N/A
Applicable Margin Rate 19.92
Face Value 10

Key Price Statistics of Valiant Laboratories Limited

The 52-week high for Valiant Laboratories Limited was ₹171.90, recorded on 08-Apr-2024. On the other hand, the 52-week low stands at ₹79.70, with the lowest value recorded on 28-Feb-2025.

The upper band for trading is ₹99.18, and the lower band is ₹66.12. The price band is 20%.

The stock's daily volatility stands at 2.53, while the annualized volatility is 48.34. The tick size for trading is ₹0.01.

Price Information Details
52 Week High (08-Apr-2024) 171.90
52 Week Low (28-Feb-2025) 79.70
Upper Band 99.18
Lower Band 66.12
Price Band (%) 20
Daily Volatility 2.53
Annualised Volatility 48.34
Tick Size 0.01

Key Securities Statistics of Valiant Laboratories Limited

Securities Information Details
Status Listed
Trading Status Active
Date of Listing 06-Oct-2023
Adjusted P/E 0
Symbol P/E 0
Index NA
Macro-Economic Sector Healthcare
Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Basic Industry Pharmaceuticals

Security Status of Valiant Laboratories Limited

Title Details
Board Status Main
Trading Segment Normal Market
Session No. -
Class of Shares Equity
SDD Compliance -
Name of Compliance Officer -

Announcements of Valiant Laboratories Limited

Subject Date
Credit Rating 19-Feb-2025
Copy of Newspaper Publication 08-Feb-2025
Integrated Filing- Financial 07-Feb-2025
General Updates 07-Feb-2025
Financial Result Updates 07-Feb-2025
Outcome of Board Meeting 07-Feb-2025
Board Meeting Intimation 31-Jan-2025
Integrated Filing- Governance 10-Jan-2025

Corporate Actions of Valiant Laboratories Limited

Face Value Purpose Ex-Date Start Date End Date
No corporate actions available

Board Meetings of Valiant Laboratories Limited

Purpose Details Att. Mtg. Date
Board Meeting Intimation VALIANT LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 07-Feb-2025 to consider and approve the Quarterly Audited Financial results of the Company for the period ended December 2024 and Other business. 07-Feb-2025
Financial Results/Other business matters To consider and approve the financial results for the period ended December 31, 2024 and other business matters 07-Feb-2025
Board Meeting Intimation VALIANT LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2024 to consider and approve the Quarterly Audited Financial results of the Company for the period ended September 2024 and Other business. 12-Nov-2024
Financial Results/Other business matters To consider and approve the financial results for the period ended September 30, 2024 and other business matters 12-Nov-2024
VALIANT LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 12-Aug-2024 to consider and approve the Quarterly Audited Financial results of the Company for the period ended June 2024 and Other business. Board Meeting Intimation 12-Aug-2024
Financial Results/Other business matters To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters 12-Aug-2024
VALIANT LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 14-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Other business. Board Meeting Intimation 14-May-2024
Financial Results/Other business matters To consider and approve the financial results for the period ended March 31, 2024 and other business matters 14-May-2024
VALIANT LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 09-Feb-2024 to inter-alia consider and approve the Audited Financial results of the Company for the Quarterly ended December 2023 . Board Meeting Intimation 09-Feb-2024
Financial Results To consider and approve the financial results for the period ended December 31, 2023 09-Feb-2024
VALIANT LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 06-Nov-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Half Yearly ended September 2023 . Board Meeting Intimation 06-Nov-2023
Financial Results To consider and approve the financial results for the period ended September 30, 2023 06-Nov-2023

Financial Results of Valiant Laboratories Limited

Company Directory of Valiant Laboratories Limited

Web Address SM Name Office Address City Pincode Telephone Email
N/A Valiant Laboratories Limited Registered Office 104, Udyog Kshetra,
Mulund Goregaon Link Road,
Mulund West,
Mumbai-400080
MUMBAI 400080 +91-249712001 complianceofficer@valiantlabs.in

Insider Trading of Valiant Laboratories Limited

Reg. Clause Acq./Disp. Sec. (No.) Sec. Value Txn Type Bcast Time
No insider trading information available

Annual Reports of Valiant Laboratories Limited

Company From Year To Year Att.
Valiant Laboratories Limited 2023 2024

Investor Complaints of Valiant Laboratories Limited

Event Calendar of Valiant Laboratories Limited

Company Purpose Details Date
Valiant Laboratories Limited Financial Results To consider and approve the financial results for the period ended September 30, 2023 06-Nov-2023
Valiant Laboratories Limited Financial Results To consider and approve the financial results for the period ended December 31, 2023 09-Feb-2024
Valiant Laboratories Limited Financial Results/Other business matters To consider and approve the financial results for the period ended March 31, 2024 and other business matters 14-May-2024
Valiant Laboratories Limited Financial Results/Other business matters To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters 12-Aug-2024
Valiant Laboratories Limited Financial Results/Other business matters To consider and approve the financial results for the period ended September 30, 2024 and other business matters 12-Nov-2024
Valiant Laboratories Limited Financial Results/Other business matters To consider and approve the financial results for the period ended December 31, 2024 and other business matters 07-Feb-2025

Share Transfers of Valiant Laboratories Limited

Company Period Reg.7 Reg.40 Reg7 Bcast Date Reg40 Bcast Date
Valiant Laboratories Limited 31-MAR-2024 11-Apr-2024 15:30:02 11-Apr-2024 17:50:05

Voting Results of Valiant Laboratories Limited

Date of Mtg. Mtg. Type Resolution R. required Total SHs % favour % against
19-DEC-2024 Postal Ballot Increase in Authorised Share Capital and consequent alteration to the Capital Clause of the Memorandum of Association Ordinary 15422 100 0
19-DEC-2024 Postal Ballot Appointment of Mr. Ashok Lakhamshi Chheda (DIN: 10776571) as Non - Executive Independent Director of the Company for one term of 5 (Five) consecutive years. Special 15422 100 0
08-AUG-2024 AGM To receive, consider and adopt the Audited Standalone andnConsolidated Financial Statements for the year ended March 31,n2024, together with the Reports of the Board of Directors andnAuditors¬タル thereon Ordinary 14663 100 0
08-AUG-2024 AGM Approval of Material Related Party Transaction(s) between Valiant Advanced Sciences Private Limited and Aarti Pharmalabs Limited Ordinary 14663 99.92 0.08
08-AUG-2024 AGM Approval of Material Related Party Transaction(s) between Valiant Advanced Sciences Private Limited and Valiant Organics Limited Ordinary 14663 99.92 0.08
08-AUG-2024 AGM Approval of Material Related Party Transaction(s) with Aarti Pharmalabs Limited Ordinary 14663 99.92 0.08
08-AUG-2024 AGM Approval of Material Related Party Transaction(s) with Valiant Organics Limited Ordinary 14663 99.92 0.08
08-AUG-2024 AGM Approval for grant of loans or to invest in Bodies Corporates ornto issue guarantee or provide security under Section 186 of thenCompanies Act, 2013 Special 14663 100 0
08-AUG-2024 AGM Creation of Charges on the Assets of the Company undernSection 180 (1) (a) of the Companies Act, 2013, to secure thenBorrowings Special 14663 100 0
08-AUG-2024 AGM Enhancement in the existing borrowing limit under Section 180 (1) (c) of the Companies Act, 2013 Special 14663 100 0
08-AUG-2024 AGM Appointment of Mr. Mulesh Savla (DIN: 07474847) as Non-Executive Independent Director of the Company Special 14663 100 0
08-AUG-2024 AGM Ratification of remuneration to the Cost Auditors for thenFinancial Year 2024-25 Ordinary 14663 100 0
08-AUG-2024 AGM Re-appointment of the Statutory Auditors of the Company Ordinary 14663 100 0
08-AUG-2024 AGM To appoint a Director in place of Mr. Paresh Shah (DIN: 08291953)nwho retires by rotation and being eligible, offers himself fornre-appointment Ordinary 14663 100 0
09-APR-2024 Postal Ballot Approval of Material Related Party Transaction(s) with Valiant Organics Limited Ordinary 15332 90.75 9.25
09-APR-2024 Postal Ballot Approval of Material Related Party Transaction(s) between Valiant Advanced Sciences Private Limited and Aarti Pharmalabs Limited Ordinary 15332 91.22 8.78

FAQs on Valiant Laboratories Limited

Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.